You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaccine Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Intrinsic Pontine Glioma Trial in Beijing (Histone H3.3-K27M Neoantigen Vaccine Therapy)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Histone H3.3-K27M Neoantigen Vaccine Therapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 18, 2022

Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-F/TRICOM, PROSTVAC-V/TRICOM, Enzalutamide (Xtandi))

Active, not recruiting
  • Prostate Cancer
  • PROSTVAC-F/TRICOM
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Jan 4, 2023

High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle

Terminated
  • High Grade Anal Canal Intraepithelial Neoplasia
  • High Grade Vulvar Squamous Intraepithelial Lesion
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +1 more
Jan 24, 2023

Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

Active, not recruiting
  • Chronic Hepatitis
  • Hepatitis C Infection
  • Electroporation-Mediated Plasmid DNA Vaccine Therapy
  • +4 more
  • Jacksonville, Florida
  • +4 more
Sep 20, 2022

Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Glioblastoma
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Transitional Cell Carcinoma Trial in New York (TICE®-strain BCG, NY-ESO-1 protein, sargramostim)

Completed
Has Results
  • Transitional Cell Carcinoma
  • TICE®-strain BCG
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Chronic Hepatitis b Trial in Adelaide (Therapeutic hepatitis B vaccine, Commercial Hepatitis B vaccine)

Not yet recruiting
  • Chronic Hepatitis b
  • Therapeutic hepatitis B vaccine
  • Commercial Hepatitis B vaccine
  • Adelaide, South Australia, Australia
    Flinders University
Mar 7, 2022

Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Glioblastoma
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)

Not yet recruiting
  • Vaccine Response
  • Atlanta, Georgia
    Hope Clinic
Aug 29, 2023

Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

Active, not recruiting
  • Malignant Neoplasm
  • aldesleukin
  • +7 more
  • Los Angeles, California
    University of California at Los Angeles (UCLA )
Dec 1, 2022

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (NY-ESO-1 peptide vaccine)

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • NY-ESO-1 peptide vaccine
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

Terminated
  • Recurrent Melanoma
  • +3 more
  • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
  • Laboratory Biomarker Analysis
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Brain Cancer, Tumor Metastases Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Brain Cancer
  • Neoplasm Metastases
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Lymphoma Trial in Houston (PCV20)

Not yet recruiting
  • Lymphoma
  • PCV20
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2023

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous

Active, not recruiting
  • Malignant Neoplasms of Brain
  • tetanus toxoid
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation

Not yet recruiting
  • Unmethylated Glioblastoma
  • Personalized Neoantigen DNA vaccine
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 14, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01 in combination with standard adjuvant therapy
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +9 more
  • Cryosurgery
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022

Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus

Active, not recruiting
  • Adult Solid Neoplasm
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022